(PITTSBURGH, Pennsylvania, September 2019) – Lumis Corp, a Pittsburgh-based healthcare simulation company, was recently awarded a Small Business Innovation Research (SBIR) Program Grant from the National Institutes of Health, National Institute on Drug Abuse; Grant Number 1R43DA050371-01 to develop curriculum to help clinical providers, emergency responders and laypeople reverse opioid overdoses in a variety of settings.
According to the Center for Disease Control and Prevention, more than 130 people die from an opioid overdose every day . To combat this crisis, the National Institute on Drug Abuse is supporting companies like Lumis and hundreds of academic and community institutions across the country to develop innovative solutions for overdose reversal interventions, better strategies for managing chronic pain, and new medications to treat opioid use disorders.
Lumis’ Insight Platform was originally designed to provide hands-on, simulation-based education that utilizes augmented reality and automated instruction for individualized, 24/7, on-demand learning. By developing an effective training curriculum for opioid overdose reversal, the Insight Platform holds immense potential to save lives, reduce stigmatized views towards harm reduction and preserve limited labor and medicinal resources for healthcare systems, local municipalities and service providers.
“We are very fortunate to receive this grant and for the opportunity to collaborate with experts in the harm reduction field,” says Doug Nelson, Lumis CEO.
Lumis plans to have a viable product available for use by March 2020, built with assistance from local and regional-based Subject Matter Experts in opioid overdose education and naloxone distribution.